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1. Introduction
Theoretically, any infectious disease with an infection source, transmission route, and
susceptible population is able to infect any population. However, studies of human develop‐
ment history, especially those of infectious disease history, have clearly shown that ethnic and
regional differences in susceptibility to some infectious diseases actually exist, even if their
infection sources and transmission routes are the same. In terms of the 40 types of new
infectious diseases that have occurred worldwide in the past 40 years, the epidemiology of
some infectious diseases (including severe acute respiratory syndrome (SARS)) has been
dominated by regional/territorial or ethnic oriented infections. Examples, along with the year
of first occurrence, include:Ebola hemorrhagic fever caused by Ebola virus (1977), Legion‐
naires' disease caused by Legionella pneumophila (1977), hemorrhagic fever with renal syndrome
caused by hantavirus (1977), T cell lymphoma leukemia caused by human T-lymphotropic
virus type I (1980), hemorrhagic colitis caused by E. coli O157:H7 (1982), hairy cell leukemia
caused by human T-lymphotropic virus type II (1982), and the British BSE (bovine spongiform
encephalopathy) that created worldwide shock. Along with the effects of infection sources and
transmission routes, the contributions of racial or genetic factors to these regional/territorial
diseases are still under discussion. Clearly, these infectious diseases occurred more frequently
and with greater severity in certain regions and ethnicities. The SARS outbreak in 2002-2003
spread mainly in Asia, especially in China; the most susceptible populations were mainland
and overseas Chinese. These observations lead us to consider the important theoretical and
practical topic of the relationship between SARS genetic predisposition and individual clinical
onset. However, the sudden disappearance of SARS also left us with many revelations.
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2. The correlation of disease genetic predisposition and MHC gene
polymorphism
It is well known that the investigation of genetic predisposition is an important topic in modern
medicine. It helps to clarify not only the fundamental reasons for patients’ individual differ‐
ences but also the pathogenesis of many diseases. Better understanding of genetic predispo‐
sition can provide prevention and treatment strategies for the corresponding diseases, an
especially important consideration for individualized disease prevention and treatment.
Modern medical studies have shown that disease is a specific life process formed by interac‐
tions of environmental factors (external) and the human body (internal). Genetic factors are
the major basis of an organism’s reactivity, including defensive immunity, the functional states
of the nervous and endocrine systems, nutritional status, psychological factors, age, gender,
etc. Among these numerous factors, genetic factors predominate because, besides external
factors, immune responses and neuropsychological and endocrine functions are constrained
by genetic factors. Even nutrition status is not based only on the quality and quantity of the
exogenous nutrient supply. It is also influenced by digestion, absorption, and utilization
functions controlled by genetic factors. Gender and age (an organism’s reactive characteristics
at different ages) are even more determined by genetic factors. Therefore, organism reactivities
determined by genetic factors have been collectively called genetic predisposition. Numerous
studies have demonstrated that many severe diseases, such as cancer, atherosclerosis, coronary
heart disease, diabetes, schizophrenia, and high blood pressure, have significant genetic
predispositions. In addition, some infectious diseases caused by bacteria and viruses have
significant individual genetic predispositions. The human immune and genetic system most
closely related to genetic predisposition to disease is the major histocompatibility complex
(MHC).
Human MHC is also named as human leucocyte antigens (HLA) system, which codes for the
most polymorphic antigen system that is known. The correlation of HLA and human diseases
has been studied for nearly 40 years. The rapid development of advanced technologies in
modern molecular biology and their wide applications to HLA studies have effectively
promoted studies of HLA mechanisms and their associations with disease, leading to signifi‐
cantly increased accuracy of disease association analysis. Many alleles have been identified as
being primarily associated with certain aspects of diseases. For example, in autoimmune
diseases, Hodgkin's disease and HLA-A1 have relative risk (RR) of 32. 0; congenital adrenal
hyperplasia and HLA-B47 have relative risk of 15. 4; ankylosing arthritis and HLA-B27 have
relative risk of 87. 4; Reiter's syndrome and HLA-B27 have relative risk of 37. 0; acute anterior
uveitis and HLA-B27 have relative risk of 10. 4; psoriasis and HLA-Cw6 have relative risk of
13. 3, etc. In infectious diseases, Hepatitis B virus associated glomerulonephritis and HLA-
DQB1*03 have relative risk of 12. 90; infection and development of AIDS are highly correlated
with HLA-A29, HLA-B35, and B57; infection and development of flu are closely correlated
with HLA-A2 antigen; hepatitis B is separately correlated with HLA-B13, B8, DR7, DR13; and
infection and development of hepatitis C are closely correlated with HLA-DRB1*0402,
DRB1*12 and DQB1*0301. Therefore, correlation studies of HLA and different diseases can
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help the identification and classification of diseases. The studies could also be treated as
auxiliary diagnostic tools. While conducting such studies, researches could further clarify the
relationships between diseases and genetic inheritance, provide genetic consulting services to
specific families, detect HLA-linked disease genes, and, most importantly, provide early
predictions and preventions of these diseases.
3. The correlation of SARS genetic predisposition and HLA gene
polymorphism
SARS virus is a recently discovered infectious pathogen that can cause severe human diseases,
and, to date, we know little about it. Knowledge of its occurrence and development pattern
remains limited, and studies of its pathogenesis, treatment, and prevention strategies remain
limited. Considering that SARS displays significant regional/territorial and ethnic and
individual specificity, and that the SARS-associated antigen epitopes are almost all related to
HLA antigen recognition, as inferred by known SARS gene and protein sequences, we
hypothesize that there is a close correlation between the occurrence of a SARS epidemic and
the HLA system.
3.1. Speculations regarding susceptible genes based on SARS coronavirus (SARS-CoV)
structure
Previous studies demonstrated that although SARS-CoV and other known coronaviruses have
less than 40%-50% homology in amino acid sequence, their structures and functions are similar
to those of other known coronaviruses. The antisera of transmissible gastro-enteritis virus
(TGEV), murine hepatitis virus (MHV), Feline infectious peritonitis virus (FIPV), and 229E
human coronavirus can inhibit the growth of cultured SARS viruses. In the known OC43 and
229E coronavirus strains, HLA-A3. 1was shown by some studies to be the receptor of OC43
and aminopeptidase N (APN), also known as metalloproteinases or CD13, and the co-receptor
of human coronavirus 229E and cats/pigs coronavirus. A recent study using molecular 3D
structure simulation showed that CD13 also interacted with the S protein of SARS virus.
Carcinoembryonic antigen (CEA) is the S protein receptor of human/rats coronavirus. The
invasion, infection, and disease caused by OC43 must be accompanied by the presence and
expression of HLA-A3. 1. The invasion, infection, and disease caused by coronavirus 229E
must be accompanied by the presence and expression of aminopeptidase N. On the other hand,
carcinoembryonic antigen may be the required co-receptor for many coronavirus infections.
Theoretically, HLA-A3.1 is the susceptible gene of SARS coronavirus, and individuals without
this susceptible gene are not easily affected or have resistance to the disease.
3.2. Population genetics studies of HLA gene polymorphism and SARS genetic
predisposition
SARS is a highly contagious disease with high disease incidence and mortality rate. The limited
diffusion mode based on East and Southeast Asian countries has indicated the existence of
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susceptible genes in these populations. This has been corroborated in numerous clinical case-
control studies, but some other studies yielded opposite results. In the 2 months immediately
following the last outbreak of SARS in Taiwan, Taiwan scholars recruited 658 employees from
hospitals who had just experienced their initial or the most severe SARS infections to help the
investigation of related infectious and genetic factors of SARS-CoV. They used an enzyme
immunoassay to test the infections of SARS-CoV and then employed western blot analysis,
antibody neutralization, and commercial SARS tests for verification. Risk evaluations were
prepared through questionnaires and sequence-specific oligonucleotide probe analysis of the
human leukocyte antigen (HLA) allele. The study showed that 3% (20/658) of the partici‐
pants were positive. A female nurse with a subclinical case was identified. Identified risk factors
of SARS-CoV infection included working in the same building, such as hospital emergency
rooms  and  infection  wards,  direct  nursing  for  SARS  patients,  and  carrying  the  HLA-
Cw*0801 allele. The SARS-CoV infection ratio of homozygous and heterozygous Cw*0801
carriers was 4. 4:1 (95% confidence interval, 1. 5-12. 9; P=0. 007). However, in September 2006,
3 years after the SARS outbreak in Taiwan, 130 diagnosed SARS patients were studied to
evaluate the correlation of their SARS antibody levels and HLA types. Western blot analysis
illustrated that 6. 9%of the participants still had anti-spike and antinuclear antibodies. HLA-
SARS case-control studies revealed that HLA-Cw*1502 and DRB1*0301 genes might be the
resistance factors of SARS infection (P<0. 05).
Another study in the Taiwan population also proved the correlation between HLA and SARS.
The researchers used PCR-sequence specific oligonucleotides probe (SSOP) to study the
genotyping of HLA type I and type II alleles. The study population included 37 suspected
SARS cases (28 fever patients were excluded from SARS) and 101 non-infected medical staff
who might have been exposed to SARS-CoV. Another control group contained 190 healthy,
non-related Taiwanese people. Initially, during the analysis of SARS infected patients and the
high-risk medical staff, the researchers found that HLA-B*4601 (OR = 2. 08, P = 0. 04, Pc = n. s.)
and HLA-B*5401 (OR = 5. 44, P = 0. 02, Pc = n. s. ) might be the most probable factors assisting
SARS-CoV infection. When comparing the “severe patient” group (selected from the SARS
patient group) and the high-risk medical staff group, the researchers found that the severity
of SARS was significantly correlated with HLA-B*4601 (P =0. 0008 or Pc=0. 0279). Until recently,
no SARS patient had been found among local Taiwanese whose genes were different from
ordinary Taiwanese. They carry no HLA-B*4601 gene but have HLA-B*1301 at a high fre‐
quency. However, the increased HLA-B*4601 allele frequency found in the suspected SARS
patient group was significantly higher in severe patient group. These results support the
hypothesis that the HLA-B*4601 gene in Asian populations is correlated with the severity of
SARS infection.
Another study also showed that SARS infection was correlated with Chinese HLA. This study
determined a strong correlation between SARS development and HLA-B*0703 (OR, 4. 08; 95%
CI, 2. 03-8. 18; P=0. 00072 [Bonferroni corrected P value, Pc<0. 0022]) and DRB1*0301 (OR, 0.
06; 95%, 0. 01-0. 47; P =0. 00008 [Bonferroni corrected, Pc<0. 0042 ]), through the human
leukocyte antigen (HLA) A, B, DR, or DQ allele type analysis of 90 serologically diagnosed
Chinese SARS patients. Compared with the expected value (0. 4%) in ordinary people, the joint
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inheritance rate of B*0703 and B60 (9. 6%; 95% CI, 4. 6% - 19%) showed a significant increase
in the SARS patient group (P = 3×10-9).
Evidences of the SARS-HLA correlation has also been found in other Asian populations. In
Vietnam 44 out of 62 SARS patients participated in a study. The control groups were 103
individuals who had contact with SARS patients and 50 individuals who had not. Compared
with the control groups, HLA-DRB1*12 occurred more often in the SARS patient group
(corrected P = 0. 042). HLA-DRB1*1202, the dominate gene in Vietnamese, showed the
strongest correlation with SARS in the dominant model (corrected P = 0. 0065 and 0. 0052,
depending on the size of the control group).
However, some studies resulted in the opposite conclusions. Xiong P, et al. conducted
correlation studies of HLA gene polymorphism and SARS in Cantonese after their initial
infection by SARS, but did not find a correlation. The study included 95 SARS rehabilitation
patients and 403 genetically unrelated healthy people (control group). HLA –A, B, and DRB1
allele analysis was conducted by sequence-specific primer polymerase chain reactions. The
severity of disease was evaluated by assisted ventilation and lymphopenia based on their
history of pulmonary infiltrates. Although the frequencies of A23, A34, B60, and DRB1*12
alleles were slightly higher in SARS group and the frequency of A33, -B58, and -B61 alleles in
SARS group were all lower than those in control group, the Pc values indicated no statistical
significance. Similarly, the correlation between HLA alleles and disease severity was not
found. Therefore, the main organization of MHC variation appears not to have significant
correlation with Cantonese SARS predisposition or severity.
4. The revelations SARS brought to people
Early in Feb. 2005 on an annual meeting of Association for the Advancement of Science
(AAAS), an American microbiologist Kathryn Holmes, who had long been engaged in
coronavirus researches, pointed out that it was not impossible to have another outbreak of
severe acute respiratory syndrome (SARS) in the world like the one 2 years ago. The SARS-
CoV used to spread in populations might only exist in laboratory samples. Her words shocked
the world. It has been 10 years since the SARS pandemic. Many scholars conducted broad and
indepth studies but have not achieved breakthroughs with respect to the origin of SARS CoV.
On the contrary, the new influenza A virus (H1N1) that spread worldwide in April 2009 was
studied thoroughly during the first 2 months of its spreading. It has 8 types of genes coming
from 4 pedigrees and is very similar to the North American popular triple ligand swine H1N1
virus. Different from other viruses, there has been no SARS patient other than lab infections
after the widespread infections in January 2004. SARS-CoV does not exist in nature or people
now. Hence the natural SARS epidemic history has some extraordinary abnormalities. What
are the reasons? The most important reason could be that there is no direct ancestor of SARS-
CoV in nature. It had an “unusual evolution”. It is very likely that it was “unnaturally”
introduced to populations, so it did not follow the normal epidemic transmission rules.
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SARS-CoV has an unordinary phylogeny. It has a fast and obvious “reverse evolution. ”
“Reverse  evolution”  is  defined  as  “regaining  the  ancestor’s  state”  and  is  an  evolution
component that commonly exists in the biosphere, including microbial communities. In the
long course of natural evolution, “reverse evolution” might be largely supplemental and it
might  coordinate  “forward  evolution”  ,  acting  as  the  twists  and  turns  of  mainstream
evolution.  However,  the  “reverse  evolution”  of  SARS-CoV  appears  earlier  and  more
powerfully, and it has more presence and lasts longer. In the early state of its epidemic, it
had already lost the genes related to host adaptability (characteristic 29-ntORF8 gene) and
presented  “reverse  evolution”  of  key  amino  acids  on  the  virulence  and  transmission-
related receptor’s binding site.  The SARS-CoV outbreak in 2003-2004 in Guangzhou was
phylogenetically closer to earlier viruses in the 2002-2003 epidemics than the later virus‐
es.  Under natural  conditions,  it  is  not  possible  that  the adaptive evolution of  Bt-SLCoV
could have developed to the human level through carnivores in such a short time. Therefore,
the only possible explanation is  that  SARS-CoV was produced through “unusual  evolu‐
tion (UE),” via processes such as like GM technology.
There have already been some debates about the technical maturity of transforming animal
virus to human virus (for example, GM technology). However, it would be indisputable now,
as in May and June 2012, a top international journal published 2 papers, which shocked the
international natural science field in 2011 and clarified this problem by facts. However,
according to some international information sources, in 2000 or earlier some scientists were
studying or had already mastered these technologies at those early dates.
Therefore, Xu D et al. reasoned that there was no storage host of SARS-CoV in nature and it
was made by “unnatural ways (GM technology)”from Bt-SLCoV, which means we had already
entered a new era where a “novel artificial virus” could cause a global epidemic. We can further
explain the unnatural origin of SARS from its apparently abnormally epidemiological and
clinical characteristics: 1) in the early and middle stages of the epidemic, all Cantonese patients
were from the west and the south of Guangzhou while there was not even 1 patient from the
north or the east; 2) During December 2003 to January 2004, 4 cases in Guangzhou had only
mild symptoms and no sustainability due to the reverse evolution of SARS-CoV in the
population. However, during March and April 2004, the outbreak from a laboratory (9 cases
and 1 death) was super transmissible, which was the same as in the 2002-2003 epidemic,
without reverse evolution; and 3) As a specific infection source, infected civets were found
only in 2 animal markets in Guangzhou and Shenzhen and could have been used for unnatural
introduction. Therefore, we are facing unprecedented threats today, and we must deal with
them together.
5. Conclusions
The investigation of the SARS in-out flow epidemic transmission network in mainland China
shows that Beijing and Guangdong were the places where the exported cases and self-
transmission cases were the most severe. Guangzhou was the origin of the transmission of
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SARS and the main import source of the early-stage regional cases of infection in most areas,
but it did not cause significant radiation of transmission to its neighboring regions. Neverthe‐
less, the in-out flow between Beijing and its neighboring regions did not start until the middle
to late stages of the epidemic transmission. The transmission, however, was able to radiate
significantly across regions. There have been no other cases reported among people and among
animals except for laboratory infections and 4 mild infections reported in Guangzhou in
December 2003 and January 2004. This is different from the trend of typical epidemic trans‐
missions, and it is different from the correlation between the HLA gene polymorphism and
SARS, as demonstrated by many studies. The HLA alleles that are closely related to the
infection of SARS, such as B*4601, B*5401, Cw0801, and DRB1*0301, as found among popula‐
tions from Taiwan, Hong Kong, and mainland China, are types of HLA alleles that are
relatively common in the Chinese population. Why were only people in limited regions
infected? Further, why did the transmission disappear rapidly?
The study of Xu D et al. appeared to provide a good explanation to the paradox between the
HLA gene polymorphism and the genetic predisposition to SARS. Because of the unusual virus
phylogeny of SARS-CoV, with rapid and evident “reverse evolution,” it is likely that SARS
CoV was produced through an unnatural mechanism (such as gene modification techniques).
The SARS CoV from the outbreak in Guangzhou during 2003-2004 was phylogenetically closer
to earlier viruses in the 2002-2003 epidemics than the later viruses, which led to its rapid
decrease in virulence. Therefore, the correlation would be expected to disappear because of
the reverse genetics of SARS-CoV, regardless of whether the susceptible gene existed in the
Chinese population. Of course, these conclusions can be supported and the nature of this
mysterious disease can be explained only with the support of a large number of valid and
convincing investigational results.
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